Madrigal Pharmaceuticals - Miami, FL
posted 27 days ago
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. We are seeking dedicated and results-driven Access and Reimbursement Managers (ARMs) to join our team. In this role, you will serve as the primary field-based resource to support practices in ensuring optimal patient access to a large pharmacy benefit specialty product. You will collaborate closely with healthcare providers and internal teams to address access barriers, deliver patient-centric solutions, and educate stakeholders on reimbursement processes.